Attributes 212% Revenue Growth to Rapid Adoption of Its End-to-End Digital Pathology Platform
LEHI, Utah, Nov. 19, 2026 – Lumea today announced that it ranked number 307 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing tech companies in North America, now in its 32nd year. Lumea grew 212% during 2022 to 2025, more than tripling its revenue in three years.
Lumea’s chief executive officer, James Thackeray, credits the growing number of labs and practices moving to fully digital pathology workflows and Lumea’s ability to connect every step from biopsy to diagnosis with the company’s 212% revenue growth. He said, “This recognition belongs to our team and to every lab, practice and pathologist who chose to go digital with us. When we connect the entire tissue journey, from the moment a biopsy is collected to the moment a diagnosis reaches the physician, patients get answers faster and more people get access to expert cancer diagnostics, no matter where they live. That mission is what drives our growth, and we’re just getting started.”
“The 2026 rankings demonstrate that established momentum and breakthrough growth can drive sustained market leadership,” said Justin Yahr, Audit & Assurance partner and National Emerging Growth Company leader, Deloitte & Touche LLP. “Nearly 70% of this year’s award winners returned as repeat honorees, reflecting the power of disciplined and sustained execution. More than 30% made the list for the first time, illustrating how quickly new players are shaping their respective sectors. Furthermore, private companies represented almost 80% of the list, a clear indication that the agility and strategic focus of private enterprises remain essential to scaling in competitive markets.”
About the 2026 Deloitte Technology Fast 500
Now in its 32nd year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2022 to 2025.
In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or proprietary technology that significantly contributes to the company’s operating revenues. Companies must have base-year (fiscal year 2022) operating revenues of at least US$50,000, and current-year (fiscal year 2025) operating revenues of at least US$5 million, with a growth rate of 50% or greater. Additionally, companies must be in business for a minimum of four years and be headquartered within North America (United States and Canada).
About Lumea
Lumea is a digital pathology company headquartered in Lehi, Utah, on a mission to expand access to fast, accurate cancer diagnostics. Lumea’s end-to-end platform digitizes the entire tissue journey, from biopsy collection with the BxChip, BxBoard and the Lumea BxCamera through BxLink and Viewer+, its CE-marked image management system, which integrates with LIS and EMR systems and an open marketplace of AI tools. Learn more at lumeadigital.com.
About Deloitte
*Please see www.deloitte.com/us/about for a detailed description of their legal structure.
